Compass Pathways is a biotech company pioneering psilocybin therapy for treatment-resistant depression. Its model combines a proprietary synthetic psilocybin formulation with psychological support, targeting individuals who have not responded to standard antidepressants. By conducting rigorous clinical trials, it aims to offer a regulated, evidence-based mental health alternative for patients, clinicians, and healthcare systems.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends